• Loading stock data…

ficlatuzumab

Eye-Catching Results at AACR 2019: A Quick Road Map

In a new series for MS Money Moves Premium Members, Chris Stang a PharmD candidate at the University of Findlay and Nationwide Pharmacy Intern will evaluate a few pieces of data releases from health … [Read more...] about Eye-Catching Results at AACR 2019: A Quick Road Map

Evaluating the Merits of AVEO’s Potential Purchase

At the end of January, the small-cap biotechnology company AVEO Oncology (AVEO) updated investors on the delayed timeline for filing with FDA for their lead compound tivozanib. This news led to a … [Read more...] about Evaluating the Merits of AVEO’s Potential Purchase